Ruth Tal-Singer, PhD1 James D. Chalmers, MD2 Paul W. Jones, MD3 Helen K. Reddel, MBBS, PhD4 Toru Oga, MD5 Claus F. Vogelmeier, MD6 Janelle Yorke, RN, PhD7 Bruce E. Miller, PhD8 for the CAAT Governance Board
Author Affiliations
- Global Allergy and Airways Patient Platform, Vienna, Austria
- Division of Respiratory Medicine and Gastroenterology, University of Dundee, Dundee, United Kingdom
- Institute for Infection and Immunity, City St Georges, University of London, London, United Kingdom
- Woolcock Institute of Medical Research, Macquarie University; Macquarie Medical School, Macquarie University; and The University of Sydney, Sydney, Australia.
- Department of Respiratory Medicine, Kawasaki Medical School, Kurashiki, Okayama, Japan.
- Department of Medicine, Pulmonary and Critical Care Medicine, University of Marburg, German Center for Lung Research, Marburg, Germany
- School of Nursing, Hong Kong Polytechnic University, Hong Kong, Special Administrative Region of China
- COPD Foundation, Miami, Florida, United States
Address correspondence to:
Ruth Tal-Singer, PhD
Global Allergy and Airways Patient Platform
Vienna, Austria
Email: rtalsinger@gaapp.org
Abstract
This article does not contain an abstract.
Citation
Citation: Tal-Singer R, Chalmers JD, Jones PW, et al; CAAT Governance Board. The Chronic Airways Assessment Test (CAAT™): Evolution from the COPD Assessment Test (CAT™). J COPD F. 2025; 12(3): 203-206. doi: http://doi.org/10.15326/jcopdf.12.3.2025.0614